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The cleaning procedure must be validated, so special attention must be devoted to the 
methods used for determination of trace amounts of drugs. A rapid, sensitive, and specific reverse 
phase high-performance liquid chromatographic (HPLC) method was developed for the quantitative 
determination of fenspiride hydrochloride residues on pharmaceutical manufacturing equipment 
surfaces. The calibration curve was linear over a concentration range from 1.0 to  
100.0 μg/ml with a correlation coefficient of 0.99994. The detection limit and quantitation limit 
were 0.41 μg/ml and 1.25 μg/ml, respectively. The developed method was validated with respect to 
specificity, linearity, limit of detection, accuracy and precision.  
________________________________________________________________________________ 
 




In pharmaceutical industries, it is very 
important step in the manufacture of 
pharmaceutical products is the cleaning of 
equipment and surfaces. The cleaning procedure 
must be validated, so special attention must be 
devoted to the methods used for analysis of 
trace amounts of drugs. 
This is necessary not only to ensure the 
quality of the next batch of different products 
but also to prevent cross-contamination; it is 
also a World Health Organisation good 
manufacturing practice (GMP) requirement [1]. 
There are two main types of sampling that have 
been found acceptable: The most desirable 
direct surface sampling of the equipment by 
using swabs and the use of the final rinse 
solution. 
Typical acceptance criteria used in the 
pharmaceutical industry are the 1/1000 dosage 
criteria (1/1000 reduction of the lowest 
therapeutic dose of the previous drug product), 
the 10 ppm criteria (no more than 10 ppm of 
any active pharmaceutical ingredient will appear 
in the next product), or the visual clean criteria 
(no residue will be visible on the equipment 
after the cleaning process). Several 
mathematical formulas were proposed to 
estabilish the acceptable residual limit [2]. 
Fenspiride hydrochloride (FH, 8-(2-
phenylethyl)-1-oxo-3,8-diazaspiro[4,5]decan-2-
one hydrochloride) is an effective drug in case 
of inflammatory diseases of otolaryngological 
system and respiratory tracts. It is also used as a 
complex therapy for bronchial asthma, allergic 
rhinitis. Its structural formula is as follow: 
 
Fenspiride hydrochloride (FH) 
In the 50 last years only several methods 
for determination of FH in pharmaceutical 
preparations and biological samples (human 
plasma and urine, horse body fluids) have been 
described. The first method for the 
quantification of fenspiride was described in 
1976 (spectrophotometric determination) [3]. 
The method for the quantification of 
fenspiride in plasma and urine which was 
described in article [4] included liquid–liquid 
extraction of analyte from the biomatrix. The 
quantification of fenspiride was run by HPLC 
method on the reversed-phase column, with 
electrochemical detection and ultraviolet 
detection. In the paper [5] fenspiride and its 
metabolites in urine were detected with the help 
of capillary gas chromatography-mass 
spectrometry method.  
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The selective LC-MS/MS method was 
developed for more than 250 basic drugs 
screening including fenspiride in the supernatant 
of enzyme hydrolysed equine urine after 
extraction on the short Oasis HLB® column [6].  
One more method based on gas 
chromatography-mass spectrometry was 
developed for narcotics and stimulants in equine 
urine screening [7].  
In the article [8] fenspiride was 
determined in human plasma using the liquid-
liquid extraction of fenspiride and the internal 
standard in 1-octanol, followed by direct 
injection of large volume aliquot (75 μL) of 1-
octanol containing the analytes in the reversed-
phase chromatography column and MS/MS 
detection.  
The article [9] describes development and 
validation of a new rapid UPLC-MS/MS 
method for the quantification of fenspiride in 
human plasma. The developed method satisfied 
all regulatory requirements and was successfully 
applied to the bioequivalence study of coated 
tablets of fenspiride. Reported methods are 
sensitive to quantitate the trace level amount of 
fenspiride hydrochloride present in swab 
samples. A literature survey revealed that no 
validated cleaning method for fenspiride 
hydrochloride is to be found. Due to their high 
sensitivity and selectivity, analytical methods 
such as liquid chromatography were previously 
used for the determination of residues to control 
cleaning procedures [10]. 
The aim of this work covered 
development and validation of the HPLC 
method for the estimation of trace level residues 
of fenspiride hydrochloride on pharmaceutical 
manufacturing equipment surfaces. The 
developed method was validated with respect to 
specificity, linearity, limit of detection, accuracy 
and precision. 
Experimental part 
Chemicals and reagents 
The certified fenspiride hydrochloride, the 
working standard was supplied by Erregierre 
S.p.A., Italy. The HPLC grade methanol and 
analytical grade sodium dihydrogen phosphate 
monohydrate and orthophosphoric acid were 
purchased from Merck. High purity water was 
prepared by using Millipore Direct-Q water 
purification system (Millipore, USA). Swabs 
(Alpha® Sampling Swab TX 715) for sampling 
were purchased from Texwipe company 
(China). 
Apparatus 
The chromatography analysis was 
performed using a Agilent 1260 LC System 
(Agilent Technologies, USA) equipped with a 
UV/visible detector. The pH of the solutions 
were measured by a pH meter (Seven Easy, 
Mettler-Toledo, Switzerland) with a glass 
electrode. All measurements were performed at 
room temperature (22°C). 
Chromatographic conditions 
The method was validated using an 
Zorbax Eclipse XDB-C18 (0,15 m x 4,6 mm) 
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5 μm column with a isocratic mobile phase 
containing a mixture of 2.76 g/L sodium 
dihydrogen phosphate monohydrate and 
methanol (80:20 v/v), pH adjusted to 3.0 with 
orthophosphoric acid. The mobile phase was 
filtered through nylon 0.22 μm membrane filters 
and degassed. The flow rate of the mobile phase 
was 1.5 ml/min with a column temperature of 
30°C and detection wavelength at 210 nm. Time 
chromatography is a 5 min, injection volume - 
50 µl.  
Standard solution preparation 
A stock solution containing 1.0 mg/mL 
fenspiride hydrochloride was prepared by an 
dissolving appropriate amount of drug in water. 
The final concentration of solution was  
10.0 μg/mL of fenspiride hydrochloride. 
Appropriate dilutions were made with diluent to 
obtain solution containing 1.0, 3.0, 5.0, 7.0, 
10.0, 20.0, 30.0, 50.0, and 100 μg/mL. 
Sample preparation (extraction 
procedure) 
The selected surfaces (10 × 10 cm2) of 
stainless steel, previously cleaned and dried, 
were sprayed with 100 μL and 200 μL of 
standard solution (0.25 mg/mL), for the positive 
swab control at two concentration levels and the 
solvent was allowed to evaporate. The total 
surface were successively wiped first in 
horizontal and secondly in a vertical way, 
starting from outside toward the center, with 
one or two swabs moistened with water to 
remove the residue from the surface. The swabs 
were placed in the 25 mL screw-cap test tubes 
containing 5 mL water (5 µg/mL and  
10 µg/mL). The tubes were placed in an 
ultrasonic bath for 15 min, and the solutions 
were analysed by HPLC.  
Results and discussion 
Acceptance limit calculation 
The acceptable limit for the drug residue must 
ensure the absence of cross contamination for 
subsequent batches manufactured in the affected 
equipment. 
The maximum allowable carryover (MACO) is 
the acceptable transferred amount from the 
previous to the following product. The MACO 
is determined based on the therapeutic dose, 
toxicity and generally 10 ppm criterion. Once 
the maximum allowable residue limit in the 
subsequent product was determined, the next 
step was the determination of the residue limit 
in terms of the contamination level of active 
ingredient per surface area of equipment. The 
total surface area of the equipment in direct 
contact with the product was accounted for in 
the calculation. The limit per surface area was 
calculated from the equipment surface area and 
the most stringent maximum allowable 
carryover. The 0.1% dose limit criterion is 
justified by the principle that an active 
pharmaceutical ingredient (API) at a 
concentration of 1/1000 of its lowest therapeutic 
dose will not produce any adverse effects on 
human health [11]. 
 The calculated limit per surface area in the case 
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of FH was 40.0 µg/swab pro 100 cm2. A 
stainless steel surface area of 10 cm×10 cm was 
chosen for practical reasons. 
Method development and optimization 
The main objective in this study has 
been to develop an HPLC method using 
isocratic conditions for the analysis of low 
quantities of fenspiride hydrochloride, trying to 
get a high peak in a short time. We selected  
210 nm for the analysis because the drug has 
sufficient absorption and low quantities of FH 
may be detected correctly. Furthermore, the 
calibration curves obtained at 210 nm show 
good linearity. The mobile phase very often 
used is the mixture of phosphate buffer and 
methanol in different proportions. Several 
mobile phases were tested, varying their 
composition and pH, to obtain the 
chromatographic separation. The sufficient 
tailing factor and plate number 
were achieved with the proposed mobile phase 
composed by solution 2.76 g/L sodium 
dihydrogen phosphate monohydrate and 
methanol (80:20 v/v), pH adjusted to 3.0 with 
orthophosphoric acid gave best resolution and 
sensitivity with a very shorter run time (5 min). 
An Zorbax Eclipse XDB-C18 (0,15 m x 4,6 mm) 
5 μm column was selected over an Zorbax 
Eclipse XDB-C18 (0,25 m x 4,6 mm) 5 μm 
column, to achieve good peak shape and 
symmetry. The injection volume was varied 
between 10 and 100 μL, finally 50 μL was 
chosen, because bigger volumes imply wider 
peaks without much enhancement of the signal-
to-noise ratio. The flow rate of the mobile phase 
was kept 1.5 mL/min and the column 
temperature was maintained at 30 °C. 
Validation of the method 
In accordance with the ICH-Guidelines on 
the validation of analytical methods [12] the 
following validation characteristics were 
examined: specificity, linearity, limit of 
detection, and limit of quantification, precision, 
and accuracy. 
System suitability  
The system suitability test was used to 
ensure that the HPLC system and procedures are 
adequate for the analysis performed. Parameters 
of this test were column efficiency (number of 
theoretical plates), asymmetry of 
chromatographic peak, and reproducibility as 
RSD of peak area of six injections of standard 
solution (10.0 μg/ml). During performing the 
system suitability test, in all cases relative 
standard deviation (RSD) of the peak areas was 
≤2.0%, the number of theoretical plates per 
column was 4000, and the USP tailing factor 
was ≤2.0.  
Specificity  
The ability of this method to separate and 
accurately measure the peak of interest indicates 
the specificity of the method. The specificity of 
the method was checked by injecting fenspiride 
hydrochloride standard, fenspiride 
hydrochloride sample, the background control 
sample, and the negative swab control. There is 
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no interference from the extracted blank swab, 
the extraction solvent and excipients used for 
the drug product (tablets) at the retention time 
of analyte peak (Figure 1). 
 
Figure 1. Overlay chromatograms of extracted blank 
swabs (1), extraction solvent (2), excipients used for the 
drug product (3), and the active compound at a 
concentration range from 1.0 to 100.0 μg/ml (4-12). 
Linearity  
The linearity of the method was 
established by injection of standard solutions at 
nine concentration levels (Figure 1) over a wide 
concentration range from 1.0 to 100.0 μg/mL. 
The calibration curve (Figure 2) was 
constructed by plotting the response area against 
the corresponding concentration injected, using 
the least square method. The calibration curve 
values of slope, intercept, and correlation 
coefficient for fenspiride hydrochloride are 
46.09218, 4.78055 and 0.99994, respectively. 
The high value of the correlation coefficient 
indicated good linearity. 
 
Figure 2. Calibration curve for determination of FH. 
Limits of detection and quantification  
The limits of detection (LOD) and 
quantification (LOQ) were determined based on 
the standard deviation of the response (y-
intercept) and the slope of the calibration curve 
at low concentration levels according to ICH 
guidelines. The LOD and LOQ for fenspiride 
hydrochloride were found to be 0.41 μg/ml and 
1.25 μg/ml, respectively. 
Precision and accuracy 
 The precision and accuracy of the 
proposed cleaning validation procedure, 
reported as relative standard deviation (RSD) 
and the recovery (%), respectively, were 
assessed by comparing the amount of analyte 
determined versus the known amount spiked at 
two different concentration levels (5.0 and 10.0 
μg/mL) with 3 replicate (n=3) for each 
investigated concentration level. The recovery 
and the RSD values (Table 1) for each level 
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illustrated good precision and accuracy of the 
method. These precision and recovery results 
are excellent for the purpose of residue 
monitoring. 
Table 1. Results of the recovery study 









5.0 90.04 3.89 
10.0 91.82 3.17 
swabs 5.0 97.24 1.54 
10.0 98.15 1.68 
 
Solution stability  
The stability of the fenspiride 
hydrochloride in the swab matrix and standard 
solution (10.0 µg/mL) was tested. The spiked 
sample and standard solution were stored at 
room temperature for 2 days. All the samples 
were injected into the HPLC system after 24 
and 48 h against freshly prepared standard 
solution. Sample and standard solution were 
stable up to two days. No changes in the 
chromatography of the stored samples were 
found, and no additional peaks were registered 
when compared with the chromatograms of the 
freshly prepared standard solution. 
Assay of swab samples  
Swab samples from diffrent locations of 
tablet press have been analyzed to determine the 
residual of FH. These samples were prepared 
and analyzed by the proposed method. Some of 
the results obtained for these samples are 
presented in table 2. 
Table 2. Determination of FH in actual swab samples 
collected from different locations of tablet press  
(100 cm2) 
Sample no MACO, µg Results, µg 
1 40 7.45 




The results of determination of trace 
amounts of FH on the tablet press surface 
evidence of satisfactory quality cleaning of the 
equipment. 
Conclusions 
A new sensitive HPLC method has been 
developed for the determination of fenspiride 
hydrochloride residues on the pharmaceutical 
manufacturing surface to control the efficiency 
of the equipment cleaning. The suggested 
method was validated in accordance with ICH 
guidelines and has the advantage of being 
simple, sensitive and suitable for routine 
analysis in a quality control laboratory. Stability 
studies show that FH samples were, at least 
stable over the investigated 48 hours. 
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